4//SEC Filing
Simon Amy 4
Accession 0000899243-23-010816
CIK 0001745999other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 8:30 PM ET
Size
9.1 KB
Accession
0000899243-23-010816
Insider Transaction Report
Form 4
Simon Amy
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-04-03$30.31/sh−4,445$134,728→ 80,962 total - Sale
Common Stock
2023-04-04$29.77/sh−10,493$312,339→ 70,469 total - Sale
Common Stock
2023-04-04$29.09/sh−1,161$33,777→ 69,308 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
- [F2]Includes 278 shares acquired by the Reporting Person under the Beam Therapeutics Inc. Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2023.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $29.505 to $30.28, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.77 to $29.10, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001963879
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 8:30 PM ET
- Size
- 9.1 KB